PERSISTENCE AND DOSE TITRATION AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB OR ADALIMUMAB

被引：0
|
作者：
Pilon, Dominic
Ding, Zhijie
Manceur, Ameur M.
Zhdanava, Maryia
Zhao, Ruizhi
Holiday, Christopher
Kachroo, Sumesh
Lefebvre, Patrick
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1562
引用
收藏
页码：S415 / S415
页数：1
相关论文
共 50 条
  • [1] Treatment Persistence Among Bio-naive Patients with Crohn's Disease Initiated on Ustekinumab and Adalimumab
    Pilon, Dominic
    Ding, Zhijie
    Manceur, Ameur M.
    Muser, Erik
    Zhdanava, Maryia
    Kinkead, Frederic
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S328 - S329
  • [2] Treatment persistence among bio-naive patients with Crohn's disease initiated on ustekinumab or adalimumab
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur M.
    Muser, Erik
    Lefebvre, Patrick
    Holiday, Christopher
    Lafeuille, Marie-Helene
    Pilon, Dominic
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (04) : 533 - 543
  • [3] Long-Term Persistence to Ustekinumab and Adalimumab Among Bio-Naive Patients With Crohn's Disease
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur M.
    Kachroo, Sumesh
    Holiday, Christopher
    Zhao, Ruizhi
    Izanec, James
    Pilon, Dominic
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S571 - S572
  • [4] SUPERIOR PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur
    Zhao, Ruizhi
    Holiday, Christopher
    Kachroo, Sumesh
    Muser, Erik
    Pilon, Dominic
    [J]. GASTROENTEROLOGY, 2023, 164 (04) : S47 - S47
  • [5] SUPERIOR PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur
    Zhao, Ruizhi
    Holiday, Christopher
    Kachroo, Sumesh
    Muser, Erik
    Pilon, Dominic
    [J]. INFLAMMATORY BOWEL DISEASES, 2023, 29 : S37 - S37
  • [6] Comparison of the efficacy of adalimumab and ustekinumab for prevention of intestinal fibrosis in bio-naive Crohn's Disease patients
    Biscanin, A.
    Tomasic, V.
    Babic, F.
    Cacic, P.
    Kordej, D. Ogresta
    Hrabar, D.
    Kralj, D.
    Dorosulic, Z.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 695 - 695
  • [7] Adalimumab was more effective in the patients with bio-naive and early Crohn's disease
    Hisamatsu, T.
    Matsuoka, K.
    Naganuma, M.
    Miyoshi, J.
    Inoue, N.
    Yajima, T.
    Mizuno, S.
    Saigusa, K.
    Nakazato, Y.
    Mori, K.
    Takeshita, K.
    Nanki, K.
    Kiyohara, H.
    Iwao, Y.
    Ogata, H.
    Kanai, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S305 - S305
  • [8] REAL-WORLD LONG-TERM TREATMENT PERSISTENCE AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE AND HISTORY OF FISTULA INITIATED ON USTEKINUMAB
    Zhdanava, Maryia
    Kachroo, Sumesh
    Boonmak, Porpong
    Burbage, Sabree
    Shah, Aditi
    Jiang, Zhuohan
    Lefebvre, Patrick
    Kerner, Caroline
    Pilon, Dominic
    [J]. INFLAMMATORY BOWEL DISEASES, 2024, 30
  • [9] PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-EXPERIENCED PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur
    Kachroo, Sumesh
    Holiday, Christopher
    Zhao, Ruizhi
    Pilon, Dominic
    [J]. GASTROENTEROLOGY, 2023, 164 (04) : S45 - S46
  • [10] PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-EXPERIENCED PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur
    Kachroo, Sumesh
    Holiday, Christopher
    Zhao, Ruizhi
    Pilon, Dominic
    [J]. INFLAMMATORY BOWEL DISEASES, 2023, 29 : S36 - S36
12345